Glenmark Pharmaceuticals Share Price

NSE

BSE

FUT

OPT

GLENMARK PHARMACEUTICALS

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Glenmark Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹2,056.35 Closed

3.3₹ 65.75

As on Sep 5, 2025, 4:01 PM IST

Glenmark Pharmaceuticals Price Performance

Today's LowToday's High

₹1,990.60₹2,056.35

₹2,056.35

52 Weeks' Low52 Weeks' High

₹1,274.70₹2,286.15

₹2,056.35

Open Price

₹1,990.60

Prev. Close

₹1,990.60

Volume

18,367

Over the last 5 years, the share price of Glenmark Pharmaceuticals has gained 34.51% CAGR. Over the past year, the corresponding return has been 20.31%.

Glenmark Pharmaceuticals’s current P/E of 39.03x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Glenmark Pharmaceuticals Peer Comparision

Name	1W(%)	1M(%)	3M(%)	6M(%)	1Y(%)	3Y(%)	5Y(%)
Glenmark Pharmaceuticals	6.87	0.24	29.73	48.29	20.31	76.91	34.51
Sun Pharmaceutical Industries	0.04	-2.29	-5.26	0.81	-12.60	21.69	25.45
Divi's Laboratories	-1.78	-6.24	-9.36	8.98	17.24	18.68	13.45
Cipla	-2.32	3.57	4.23	9.46	-4.63	14.82	16.72
Torrent Pharmaceuticals	0.62	-0.23	13.90	20.10	4.02	33.07	20.80
Dr. Reddy's Laboratories	0.44	4.51	-1.66	12.60	-5.30	14.60	7.48
Mankind Pharma	3.23	-2.51	8.05	11.49	3.27	21.45	12.37
Zydus Lifesciences	3.40	5.63	6.13	14.26	-9.05	39.82	22.33
Lupin	2.27	3.90	-2.97	-3.66	-15.39	43.67	15.92
Abbott India	-0.79	-6.05	-1.42	-0.43	5.42	19.72	13.68
Alkem Laboratories	0.58	8.45	10.17	13.64	-15.02	20.67	13.59
Aurobindo Pharma	1.69	-3.24	-9.87	-4.33	-31.81	24.63	5.64
Biocon	4.45	-2.35	10.03	12.06	-4.96	7.51	-2.93
Laurus Labs	2.74	2.62	37.33	55.29	79.92	16.07	29.66
GlaxoSmithKline Pharmaceuticals	-0.24	-2.23	-19.74	3.15	-1.27	24.44	11.30
Anthem Biosciences	1.37	12.75	13.61	13.61	13.61	4.35	2.58
Cohance Lifesciences	5.19	-3.75	-12.98	-21.28	-19.61	23.33	22.36
Ipca Laboratories	-3.18	-6.24	-3.59	-1.93	-7.37	14.67	5.57
Ajanta Pharma	5.65	-0.67	1.69	2.28	-21.34	24.71	20.83
Gland Pharma	1.95	-3.11	16.77	20.77	0.66	-8.34	0.90

Over the last one year, Glenmark Pharmaceuticals has gained 20.31% compared to peers like Sun Pharmaceutical Industries (-12.60%), Divi's Laboratories (17.24%), Cipla (-4.63%). From a 5 year perspective, Glenmark Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (25.45%) and Divi's Laboratories (13.45%).

Glenmark Pharmaceuticals Financials

Glenmark Pharmaceuticals Stock Technicals

Moving Average

Day	SMA	EMA
5	1,942.23	1,966.96
10	1,942.04	1,963.69
20	1,983.95	1,979.85
50	1,992.05	1,938
100	1,731.12	1,816.22
200	1,606.38	1,669.03

Glenmark Pharmaceuticals Share Holding Pattern

In the latest quarter, Glenmark Pharmaceuticals saw a drop in promoter holding to 46.64%, while DII stake increased to 17.64%, FII holding fell to 20.62%, and public shareholding moved down to 15.05% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Glenmark Pharmaceuticals Stock Mutual Fund Holdings

Fund Name	No. Of Shares	% of AUM	Amount Invested(in ₹ crore)
HDFC Mid-Cap Opportunities Fund - Regular Plan	1,20,78,021	3.07	2,577.57
Mirae Asset Large & Midcap Fund	18,62,096	0.98	397.39
Invesco India Mid Cap Fund	16,76,417	4.59	357.76
Invesco India Contra Fund	16,62,235	1.84	354.74
Invesco India Large & Mid Cap Fund	13,42,939	3.58	286.6
Kotak Equity Arbitrage Fund - Regular Plan	13,15,500	0.39	280.74
Mirae Asset ELSS Tax Saver Fund	11,35,209	0.93	242.27
Mirae Asset Healthcare Fund	9,86,043	7.24	210.43
Mahindra Manulife Multi Cap Fund	9,35,000	3.48	199.54
HDFC Balanced Advantage Fund - Regular Plan	8,85,046	0.19	188.88

View All Mutual Funds

Glenmark Pharmaceuticals Futures

Price	(%) As on Invalid Date IST
Open Interest	(%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Glenmark Pharmaceuticals Options

Price	(%) Not traded today
Open Interest	(%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Glenmark Pharmaceuticals Corporate Actions

Date Time	Announcement
Sep 05, 2025, 3:18 PM IST	Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sep 02, 2025, 3:58 PM IST	Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Aug 30, 2025, 1:05 AM IST	Glenmark Pharma - Intimation Of Record Date For Dividend
Aug 30, 2025, 1:00 AM IST	Glenmark Pharma - Business Responsibility and Sustainability Reporting (BRSR)
Aug 30, 2025, 12:39 AM IST	Glenmark Pharma - Reg. 34 (1) Annual Report.

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/11/1977 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH1977PLC019982 and registration number is 019982. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 9226.41 Cr. and Equity Capital is Rs. 28.22 Cr. for the Year ended 31/03/2025.

Industry
Pharmaceuticals
Address
B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai Maharashtra 400026
Contact
complianceofficer@glenmarkpharma.com http://www.glenmarkpharma.com

Management

Mr. Glenn Saldanha
Chairman & Managing Director
Mrs. Cherylann Pinto
Executive Director - Corporate Affairs
Mr. V S Mani
Executive Director & Global CFO
Mrs. B E Saldanha
Non Executive Director
Ms. Saira Ramasastry
Ind. Non-Executive Director
Mrs. Vijayalakshmi Iyer
Ind. Non-Executive Director
Mr. Rajesh V Desai
Ind. Non-Executive Director
Mr. Dipankar Bhattacharjee
Ind. Non-Executive Director

FAQs on Glenmark Pharmaceuticals Share Price

What is the share price of Glenmark Pharmaceuticals?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Glenmark Pharmaceuticals is ₹2,056.35 as on Sep 05, 2025.

What kind of stock is Glenmark Pharmaceuticals?

The Glenmark Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.

What is the Market Cap of Glenmark Pharmaceuticals?

The market cap of Glenmark Pharmaceuticals is ₹58,030.36 Cr as on Sep 05, 2025.

What are today's High and Low prices of Glenmark Pharmaceuticals?

Today’s highest and lowest price of Glenmark Pharmaceuticals are ₹2,056.35 and ₹1,990.60.

What are the 52 Week High and 52 Week Low of Glenmark Pharmaceuticals?

The 52-week high/low is the highest and lowest price at which Glenmark Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Glenmark Pharmaceuticals is ₹2,286.15 and 52-week low of Glenmark Pharmaceuticals is ₹1,274.70 as on Sep 05, 2025.

How has the Glenmark Pharmaceuticals performed historically in terms of returns?

The Glenmark Pharmaceuticals has shown returns of 3.3% over the past day, 0.24% for the past month, 29.73% over 3 months, 20.31% over 1 year, 76.91% across 3 years, and 34.51% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Glenmark Pharmaceuticals?

P/E ratio of and PB ratio of Glenmark Pharmaceuticals are 39.03 and 2.42 on Sep 05, 2025. While the company gives a dividend yield of 0.12 per annum.

Market Data

1 Day	3.3%
1 Month	0.24%
3 Months	29.73%
YTD	27.4%
1 Year	20.31%
3 Years	76.91%
5 Years	34.51%
10 Years	7.47%

Face Value (Rs) 1.00	EPS-TTM (Rs) 52.69	Dividend/Share (Rs) 2.50
PE Ratio (x) 39.03	PB Ratio (x) 2.42	EV/EBITDA (x) 17.83
Div. Yield (%) 0.12	Beta (1M) 0.62